Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04717934 · ClinicalTrials.gov registry record · NA
Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 211
- Enrollment target
NCT04717934 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 211 participants.
The verdict
NCT04717934, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
Study Summary
Main study: Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GAL1906 for the correction of wrinkles in the décolletage area. Sub-study: To evaluate imaging interpretation of mammograms in subjects who were enrolled and treated in the 43USRV1906 main study. The sub-study will determine if hyaluronic acid injections in the décolletage interfere with diagnosis or interpretation of mammogram results.
Interventions
- DEVICE GAL1906
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2025-06-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04717934
The ClinicalTrials.gov registry entry for NCT04717934 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 211 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GAL1906 is the first listed.
NCT04717934 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04717934 about?
NCT04717934 is a clinical study titled "Main Study: A Study to Evaluate the Effectiveness and Safety of GAL1906 for Correction of Wrinkles in the décolletage Area Sub-study: A Follow-up Study to Evaluate the Analysis of Mammograms Following Treatment for Correction of Wrinkles in Décolletage Area in the Investigational Study 43USRV1906". Main study: Randomized, evaluator-blinded, no treatment controlled multicenter study to evaluate safety and effectiveness of GAL1906 for the correction of wrinkles in the décolletage area. Sub-study: To evaluate imaging interpretation of mammograms in subjects who were enrolled and treated in the 4...
What is the current status of trial NCT04717934?
This trial is currently completed. It is a NA study. The enrollment target is 211 participants. The study started on 2025-02-11. Estimated completion is 2025-06-13.
What interventions are being tested in trial NCT04717934?
The interventions under investigation include: GAL1906 (DEVICE).
Who is sponsoring clinical trial NCT04717934?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.